Tawar Partners Successfully Advised Cairo Clinical Lab on Acquisition of 100% of Its Shares by City Lab

shirovski — Tue, 02 Apr 2024 13:37:18 +0000

Cairo, April 2024: Tawar Partners, Egyptian based Investment Bank is pleased to announce that it had advised Cairo Clinical Lab, a leading lab chain with network of 18 branches covering multiple zones in Cairo & Giza, on 100% Acquisition of its shares by City Labs in a deal worth EGP 55 million.

City Labs is an Egyptian lab chain listed on Nile Exchange with 26 branches present in north of Egypt recently backed by consortium composed of Saudi Qemt El Mashreq and Premium Diagnostics. This acquisition comes as part of their plan to invest more than EGP 250 million in expansions in additional labs, specialized clinics and IVF centers.

Tawar Partners acted as exclusive sell-side financial advisor on this transaction.
Our Execution team was led by Ahmed Abou Zeid Director and Zeyad Waly Associate who worked closely with deal stakeholders to ensure a successful transaction.

About Cairo Clinical Lab: Cairo Clinical Lab is ranked among the top lab chains present in Cairo with strong dominance in the south of Cairo in Maadi, Mokattam, and Helwan. Cairo Clinical Lab was established in 2018, created from an indirect spin off from one of the long-established reputable Labs Cairo Lab.

About Tawar Partners: Tawar Partners is an Investment Banking boutique based in Egypt. Tawar Partners offers a broad range of financial services including M&A Advisory, Debt Financing Advisory Equity Financing Advisory, and Capital Structuring Advisory. Tawar Partners offers its clients a unique experience in achieving their financial goals as it has ties with local and global market leaders. Thus, connecting their clients with the right partners.